Status:

COMPLETED

Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine

Lead Sponsor:

Novartis Vaccines

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Meningococcal Meningitis

Eligibility:

All Genders

37-63 years

Phase:

PHASE3

Brief Summary

The primary objective was to evaluate the persistence of bactericidal antibodies in children 40 and 60 months of age previously enrolled in the V59P14 (NCT00474526) study who received Novartis MenACWY...

Eligibility Criteria

Inclusion

  • Children eligible to be enrolled in the study are those whose parents provide written informed consent, and are in generally good health based on the clinical judgment of the investigators.
  • Group 1 and 2 (Follow up) subjects must be 40 +/- 3 months of age at the time of enrollment and participated in the original V59P14 study (NCT00474526).
  • Group 3 and 4 (Naïve) subjects must be healthy, meningococcal vaccine-naïve children ages 40 +/- 3 months (Group 3) or 60 +/-3 months (Group 4) at the time of enrollment, respectively.

Exclusion

  • Serious, acute, or chronic illnesses are reasons for exclusion.
  • Subjects who have received any vaccine (excluding influenza vaccines) 28 days preceding enrollment visit. Influenza vaccines (including FluMist®) are excluded for the 14 days prior to the enrollment visit.
  • Subjects who have received any meningococcal vaccine since birth (Groups 3 \& 4 -naive) or last study dose in V59P14 (NCT00474526) trial (Groups 1 \& 2 - follow on).

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2013

Estimated Enrollment :

433 Patients enrolled

Trial Details

Trial ID

NCT01148017

Start Date

July 1 2010

End Date

April 1 2013

Last Update

August 14 2017

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615

Birmingham, Alabama, United States, 35205

2

Premier Health Research 9317 Firestone Blvd.

Downey, California, United States, 90241

3

Kaiser Permanente Oakland 3505 Broadway, 6th Floor, Room 624

Oakland, California, United States, 94611

4

Center for Clinical Trials, LLC 16415 S. Colorado Ave., Suite 308

Paramount, California, United States, 90723